Associated Papers
Corrigendum to "Generation of two human iPSC lines with Exon 3 mutations in BLC2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients" [Stem Cell Res. 67 (2023) 103019].
Zushin PH et al.
Stem Cell Research, 2025
Cardiomyopathy genetic testing: insights into demographics, counseling, and cascade screening.
Bui QM et al.
Future Cardiology, 2025
40200748 (PubMed )
Supplement: IFCA_A_2484128_SM1099.xlsx › Sheet1
Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients.
Zushin PH et al.
Stem Cell Research, 2023
Genetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies.
Qu HQ et al.
Journal of the American Heart Association, 2022
BAG3 mutation in a patient with atypical phenotypes of myofibrillar myopathy and Charcot-Marie-Tooth disease.
Kim SJ et al.
Genes & Genomics, 2018
A patient-specific engineered tissue model of BAG3-mediated cardiomyopathy.
Morsink MAJ et al.
Journal of Tissue Engineering, 0
Select a paper to view details